Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net income	$ 27.4	$ 13.7
Loss from discontinued operations, net of benefit for income taxes of $1.3 and $0.8	(4.3)	(3.1)
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Depreciation and amortization	73.4	74.0
Stock-based compensation expense	4.7	6.2
Provision (benefit) for deferred income taxes	(2.1)	(12.4)
Net gains on lease portfolio sales, excluding sales-type leases	(2.1)	(13.5)
Gains on dispositions of property and other assets	(0.7)	(1.0)
Gains on insurance recoveries from property damage	0.0	(1.2)
Non-cash interest expense	3.4	2.6
Other	0.5	(1.9)
Changes in operating assets and liabilities:
(Increase) decrease in receivables	(118.1)	2.8
(Increase) decrease in inventories	41.2	(3.3)
(Increase) decrease in other assets	(5.1)	7.3
Increase (decrease) in accounts payable	30.6	11.6
Increase (decrease) in accrued liabilities	(1.5)	14.7
Increase (decrease) in other liabilities	0.6	(0.2)
Net cash provided by operating activities – continuing operations	56.5	102.5
Net cash used in operating activities – discontinued operations	(4.3)	(3.1)
Net cash provided by operating activities	52.2	99.4
Investing activities:
Proceeds from dispositions of property and other assets	3.9	4.9
Lease portfolio sales	24.2	56.7
Capital expenditures – lease fleet	147.5	191.5
Capital expenditures – operating and administrative	(4.6)	(7.1)
Acquisitions, net of cash acquired	0.0	(66.2)
Proceeds from insurance recoveries	0.0	1.2
Equity investments	0.0	1.1
Net cash used in investing activities	(124.0)	(203.1)
Financing activities:
Payments to retire debt	(803.8)	(149.6)
Proceeds from Debt, Net of Issuance Costs	909.9	246.3
Payments to settle contingent consideration liability	(8.0)	0.0
Dividends paid to common shareholders	(23.0)	(21.1)
Purchase of shares to satisfy employee tax on vested stock	(0.3)	(0.3)
Distributions to noncontrolling interest	(3.0)	(2.9)
Net cash provided by financing activities	71.8	72.4
Net increase (decrease) in cash, cash equivalents, and restricted cash	0.0	(31.3)
Cash, cash equivalents, and restricted cash at beginning of period	235.1	294.3
Cash, cash equivalents, and restricted cash at end of period	$ 235.1	$ 263.0